FIRM FIXED PRICE

ALBA BIOSCIENCE, INC. - QUOTIENT ALBACYTE - ALBACLONE BLOOD BANK REAGENTS FOR THE MINNEAPOLIS VA LABORATORY ONLY.

PIID: 36C26325N0159
Signed Date: Feb 17, 2026Effective Date: Oct 1, 2024End Date: Closed on Sep 30, 2025
Award $
$20K
Vendor
ALBA BIOSCIENCE, INC.
NAICS
325413
Signed Date
Feb 17, 2026

Key Details

Dollars Obligated
$19,807.03
Base & All Options
$-4,747.52
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
CHICAGO, IL, 606071670, CD-IL-07

Description

QUOTIENT ALBACYTE - ALBACLONE BLOOD BANK REAGENTS FOR THE MINNEAPOLIS VA LABORATORY ONLY.

Context & Analysis

On Feb 17, 2026, Department of Veterans Affairs obligated $19,807.03 to ALBA BIOSCIENCE, INC. for quotient albacyte - albaclone blood bank reagents for the minneapolis va laboratory only.. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in CHICAGO, IL.

Contractor Information

UEI: V6KNKL6BDHL7
CAGE Code: 5TXY0
Location: CHICAGO, IL

Stay Updated

Get notified about new opportunities matching your interests.

Related